VALIANT LABORATORIES
Back to All Ratios
|
VALIANT LABORATORIES Last 5 Year EV/Core EBITDA History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
EV/Core EBITDA(x) | 472.93 | 2.27 |
What is the latest EV/Core EBITDA ratio of VALIANT LABORATORIES ?
Year | EV/Core EBITDA |
---|---|
Mar2024 | 472.93 |
Mar2023 | 2.27 |
How is EV/Core EBITDA of VALIANT LABORATORIES Trending?
Years | EV/Core EBITDA | % Change | |
---|---|---|---|
Mar2024 | 472.93 | 20,733.92 | |
Mar2023 | 2.27 | - |
Other Financial Ratios of VALIANT LABORATORIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹471.9 Cr | 0.5% | -3.9% | -20% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹378,999.0 Cr | -0.4% | -3% | -14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,635.0 Cr | 0.6% | -3.1% | 20.2% | Stock Analytics | |
CIPLA | ₹127,544.0 Cr | 0% | 5.2% | -5.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,050.0 Cr | 0.8% | -1.9% | 2.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,373.0 Cr | 0.1% | 3.5% | -10.6% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | 0.5% |
-3.9% |
-20% |
SENSEX | -0.3% |
-0.8% |
-1.9% |
You may also like the below Video Courses